These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 24084367)

  • 1. MicroRNA-148a: a potential therapeutic target for cancer.
    Chen Z; Ma T; Huang C; Zhang L; Xu T; Hu T; Li J
    Gene; 2014 Jan; 533(1):456-7. PubMed ID: 24084367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of Microrna-148a in Cancer-Associated Fibroblasts from Oral Cancer Promotes Cancer Cell Migration and Invasion by Targeting Wnt10b.
    Min A; Zhu C; Peng S; Shuai C; Sun L; Han Y; Qian Y; Gao S; Su T
    J Biochem Mol Toxicol; 2016 Apr; 30(4):186-91. PubMed ID: 26709120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Interplay Between miR-148a and DNMT1 Might be Exploited for Pancreatic Cancer Therapy.
    Zhan Q; Fang Y; Deng X; Chen H; Jin J; Lu X; Peng C; Li H; Shen B
    Cancer Invest; 2015; 33(7):267-75. PubMed ID: 25950085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Nanovaccine with MicroRNA-148a Inhibition Reprograms Tumor-Associated Dendritic Cells by Modulating miR-148a/DNMT1/SOCS1 Axis.
    Liu L; Yi H; Wang C; He H; Li P; Pan H; Sheng N; Ji M; Cai L; Ma Y
    J Immunol; 2016 Aug; 197(4):1231-41. PubMed ID: 27421476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.
    Huang J; Wang Y; Guo Y; Sun S
    Hepatology; 2010 Jul; 52(1):60-70. PubMed ID: 20578129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of microRNA-148a in patients with early relapse of stage II stage and III colorectal cancer after curative resection.
    Tsai HL; Yang IP; Huang CW; Ma CJ; Kuo CH; Lu CY; Juo SH; Wang JY
    Transl Res; 2013 Oct; 162(4):258-68. PubMed ID: 23933284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.
    Zhao L; Sun Y; Hou Y; Peng Q; Wang L; Luo H; Tang X; Zeng Z; Liu M
    Int J Biochem Cell Biol; 2012 Nov; 44(11):2051-9. PubMed ID: 22964023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidrug Modulated Expression of MiR--152 and MiR-148a Reverse Cisplatin Resistance in Ovarian Cancer Cells: An Experimental In-vitro Study.
    Khajehnoori S; Zarei F; Mazaheri M; Dehghani-Firoozabadi A
    Iran J Pharm Res; 2020; 19(3):509-519. PubMed ID: 33680048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockage of TGFβ-SMAD2 by demethylation-activated miR-148a is involved in caffeic acid-induced inhibition of cancer stem cell-like properties in vitro and in vivo.
    Li Y; Jiang F; Chen L; Yang Y; Cao S; Ye Y; Wang X; Mu J; Li Z; Li L
    FEBS Open Bio; 2015; 5():466-75. PubMed ID: 26106521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
    Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
    Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression.
    Murata T; Takayama K; Katayama S; Urano T; Horie-Inoue K; Ikeda K; Takahashi S; Kawazu C; Hasegawa A; Ouchi Y; Homma Y; Hayashizaki Y; Inoue S
    Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):356-61. PubMed ID: 20820187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues.
    Zhang QH; Sun HM; Zheng RZ; Li YC; Zhang Q; Cheng P; Tang ZH; Huang F
    Gene; 2013 Sep; 527(1):26-32. PubMed ID: 23791657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B.
    Cheng P; Chen C; He HB; Hu R; Zhou HD; Xie H; Zhu W; Dai RC; Wu XP; Liao EY; Luo XH
    J Bone Miner Res; 2013 May; 28(5):1180-90. PubMed ID: 23225151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cloning of hsa-miR-148a and construction of its retroviral expression vector].
    Xu XH; Quan TY; Zeng WX; Chen XJ; Li WM
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1545-7, 1557. PubMed ID: 20650762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis.
    Wang J; Li J; Wang X; Zheng C; Ma W
    Biochem Biophys Res Commun; 2013 Sep; 439(1):47-53. PubMed ID: 23962428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
    Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
    Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.
    Zhang Y; Guo X; Xiong L; Kong X; Xu Y; Liu C; Zou L; Li Z; Zhao J; Lin N
    FEBS Lett; 2012 Dec; 586(24):4362-70. PubMed ID: 23178713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism.
    Ji W; Yang L; Yuan J; Yang L; Zhang M; Qi D; Duan X; Xuan A; Zhang W; Lu J; Zhuang Z; Zeng G
    Carcinogenesis; 2013 Feb; 34(2):446-53. PubMed ID: 23125218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.